Humacyte to Present at Upcoming Investor Conferences in
DURHAM, N.C., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform
Globe Newswire27-02-2023, 19:02
LambdaTest announces Delta Awards in Testing 22-06-2023, 22:00